These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15821422)

  • 1. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?
    Yuyun MF; Adler AI; Wareham NJ
    Curr Opin Nephrol Hypertens; 2005 May; 14(3):271-6. PubMed ID: 15821422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade.
    Menne J; Chatzikyrkou C; Haller H
    J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.
    Agewall S; Wikstrand J; Ljungman S; Herlitz H; Fagerberg B
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):337-42. PubMed ID: 7619345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microalbuminuria--a new cardiovascular risk factor?].
    Eisenberger U; Huynh-Do U
    Ther Umsch; 2006 Sep; 63(9):565-8. PubMed ID: 17048169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibition and microalbuminuria development: meaningful predictor of kidney disease progression.
    De Silva L; Weir MR
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):437-43. PubMed ID: 20644476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of albuminuria in hypertension and heart guidelines.
    Bakris G
    Kidney Int Suppl; 2004 Nov; (92):S124-5. PubMed ID: 15485406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade albuminuria and cardiovascular risk : what is the evidence?
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Paar WD; Bramlage P; Pittrow D; Böhm M
    Clin Res Cardiol; 2007 May; 96(5):247-57. PubMed ID: 17453140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
    Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JF; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Manfreda VM; Gentile G; Strippoli GF
    Nephrol Dial Transplant; 2011 Sep; 26(9):2827-47. PubMed ID: 21372254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the significance of microalbuminuria.
    MacIsaac RJ; Jerums G; Cooper ME
    Curr Opin Nephrol Hypertens; 2004 Jan; 13(1):83-91. PubMed ID: 15090864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary prevention of diabetic nephropathy].
    Trevisan R
    G Ital Nefrol; 2012; 29 Suppl 58():S49-53. PubMed ID: 23229603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.
    Agewall S; Wikstrand J; Ljungman S; Fagerberg B
    Am J Cardiol; 1997 Jul; 80(2):164-9. PubMed ID: 9230153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary albumin excretion and the renin-angiotensin system in cardiovascular risk management.
    Van de Wal RM; Voors AA; Gansevoort RT
    Expert Opin Pharmacother; 2006 Dec; 7(18):2505-20. PubMed ID: 17150005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria and hypertension.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Minerva Med; 2005 Aug; 96(4):261-75. PubMed ID: 16179893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.